Drug Clearance in Patients with Inflammatory Bowel Disease Treated with Biologics

Biological therapy is very effective for treating patients with moderate to severe inflammatory bowel disease (IBD). However, up to 40% can have primary non-response, and up to 50% of the patients can experience a loss of response to anti-tumor necrosis factor therapy. These undesirable outcomes can...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of Clinical Medicine 2023, Vol.12 (22)
Hauptverfasser:	Deyhim, Tina, Cheifetz, Adam S, Papamichael, Konstantinos
Format:	Report
Sprache:	eng
Schlagworte:	Chemical properties Drug metabolism Drug therapy Inflammatory bowel diseases Monoclonal antibodies Patient outcomes Pharmacology, Experimental Physiological aspects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!